Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Skin treatments can improve both skin health and emotional well-being, but they require careful management of patient expectations and potential addiction risks.

There are various tools available to help psoriasis patients manage their condition, but their effectiveness is unclear and they face issues like lack of financial support.

The conclusion is that using light-sheet fluorescence microscopy with a special solution can effectively create detailed 3D images of human skin for dermatological research.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Alopecia areata does not affect areas with psoriasis plaques.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Imipramine and pseudoephedrine treatment can effectively restore normal ejaculation in patients with diabetes, increasing their chances for pregnancy.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Fisetin may help treat psoriasis and reduce skin inflammation.

Applying pseudoceramide improved skin and hair health.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Sebaceous gland atrophy and abnormal function may contribute to hair loss in psoriasis.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Hair loss can significantly affect mental health.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

People with psoriasis have more health problems, including autoimmune diseases, than those without it.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Some drugs for inflammation may cause psoriasis-like hair loss.